Patents by Inventor Luke CEO

Luke CEO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4
    Publication number: 20240391913
    Abstract: The technology described herein is directed to IL-4 and/or IL-13 inhibitors and uses thereof.
    Type: Application
    Filed: May 24, 2024
    Publication date: November 28, 2024
    Applicants: Trustees of Boston University, Massachusetts Institute of Technology
    Inventors: Arturo Vegas, Sean Quinnell, Daniel Sheehy, Kelly Tan, Luke Ceo, Stephen Thomas Nestor, Angela Nicole Koehler, Becky Leifer, Shelby Doyle
  • Small molecule inhibitors of Interleukin-4
    Patent number: 12043621
    Abstract: The technology described herein is directed to IL-4 and/or IL-13 inhibitors and uses thereof.
    Type: Grant
    Filed: March 19, 2021
    Date of Patent: July 23, 2024
    Assignees: Trustees of Boston University, Massachusetts Institute of Technology
    Inventors: Arturo Vegas, Sean Quinnell, Daniel Sheehy, Kelly Tan, Luke Ceo, Stephen Thomas Nestor, Angela Nicole Koehler, Becky Leifer, Shelby Doyle
  • SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4
    Publication number: 20210317114
    Abstract: The technology described herein is directed to IL-4 and/or IL-13 inhibitors and uses thereof.
    Type: Application
    Filed: March 19, 2021
    Publication date: October 14, 2021
    Applicants: TRUSTEES OF BOSTON UNIVERSITY, MASSACHUSETTS INSTITUTE OF TECHNOLOGY
    Inventors: Arturo VEGAS, Sean QUINNELL, Daniel SHEEHY, Kelly TAN, Luke CEO, Stephen Thomas NESTOR, Angela Nicole KOEHLER, Becky LEIFER, Shelby DOYLE